Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
For the full year,net profit rose 17.21% to Rs 2568.00 crore in the year ended March 2026 as against Rs 2191.00 crore during the previous year ended March 2025. Sales rose 12.82% to Rs 10560.00 crore in the year ended March 2026 as against Rs 9360.00 crore during the previous year ended March 2025.
Profit before tax (PBT) stood at Rs 963 crore, up 11.46% YoY from Rs 864 crore in the corresponding period last year.
Total expenses rose 11.95% YoY to Rs 2,023 crore in Q4 FY26, with the cost of materials at Rs 1,214 crore (up 30.4% YoY) and employee benefit expenses at Rs 381 crore (up 8.86% YoY) during the period under review.
The company reported a forex gain of Rs 90 crore in Q4 FY26 as against a forex gains of Rs 10 crore for the corresponding quarter of the previous year.
On a full-year basis, the company's consolidated net profit rose 17.21% to Rs 2,568 crore on a 12.82% rise in revenue to Rs 10,560 crore in FY26 over FY25.
The company’s board has recommended a final dividend of Rs 30 per equity share of face value Rs 2 (1,500%) for FY26, subject to shareholder approval at the 36th AGM. The AGM will be held on 10 August 2026, with 24 July 2026 as the record date for dividend eligibility.
Divis Laboratories is engaged in the manufacture of active pharmaceutical ingredients, intermediates, and nutraceutical ingredients.
Shares of Divis Laboratories rose 0.36% to settle at Rs 6,885 on 22 May 2026.
Divis Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 6722, up 1.07% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.06% on the day, quoting at 24018.3. The Sensex is at 76839.15, down 0.23%. Divis Laboratories Ltd has gained around 14.91% in last one month.
Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has gained around 10.1% in last one month and is currently quoting at 23568.95, up 2.16% on the day. The volume in the stock stood at 1.33 lakh shares today, compared to the daily average of 2.86 lakh shares in last one month.
The benchmark May futures contract for the stock is quoting at Rs 6779, up 1.68% on the day. Divis Laboratories Ltd is up 9.34% in last one year as compared to a 1.62% slide in NIFTY and a 12.19% slide in the Nifty Pharma index.
The PE of the stock is 68.65 based on TTM earnings ending December 25.
Divis Laboratories Ltd fell for a fifth straight session today. The stock is quoting at Rs 6125.5, down 1.77% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.61% on the day, quoting at 25538.45. The Sensex is at 83093.05, down 0.57%.Divis Laboratories Ltd has eased around 5.93% in last one month.Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has eased around 3.39% in last one month and is currently quoting at 22217.05, down 0.3% on the day. The volume in the stock stood at 2.19 lakh shares today, compared to the daily average of 4.16 lakh shares in last one month.
The benchmark January futures contract for the stock is quoting at Rs 6138, down 1.86% on the day. Divis Laboratories Ltd jumped 2.08% in last one year as compared to a 9.4% rally in NIFTY and a 0.15% fall in the Nifty Pharma index.
The PE of the stock is 65.83 based on TTM earnings ending September 25.
Divis Laboratories Ltd dropped for a fifth straight session today. The stock is quoting at Rs 6411, down 0.1% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.39% on the day, quoting at 25929.6. The Sensex is at 84872.4, down 0.31%.Divis Laboratories Ltd has eased around 5.78% in last one month.Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has increased around 2.33% in last one month and is currently quoting at 22905, down 0.22% on the day. The volume in the stock stood at 87213 shares today, compared to the daily average of 3.14 lakh shares in last one month.
The benchmark December futures contract for the stock is quoting at Rs 6450.5, up 0.12% on the day. Divis Laboratories Ltd jumped 2.47% in last one year as compared to a 5.98% rally in NIFTY and a 1.93% spurt in the Nifty Pharma index.
The PE of the stock is 67.76 based on TTM earnings ending September 25.